mTOR inhibitors in pediatric liver transplant recipients

Dumortier, Jérôme; Couchonnal, Eduardo; Lacaille, Florence; Rivet, Christine; Debray, Dominique; Boillot, Olivier; Lachaux, Alain; Ackermann, Oanez; Gonzales, Emmanuel; Wildhaber, Barbara; Jacquemin, Emmanuel; Mclin, Valérie Anne

doi:10.1016/j.clinre.2018.11.010

Scientific article

English

mTOR inhibitors in pediatric liver transplant recipients

ContributorsDumortier, Jérôme; Couchonnal, Eduardo; Lacaille, Florence; Rivet, Christine; Debray, Dominique; Boillot, Olivier; Lachaux, Alain; Ackermann, Oanez; Gonzales, Emmanuel; Wildhaber, Barbara; Jacquemin, Emmanuel; Mclin, Valérie Anne

Published inClinics and Research in Hepatology and Gastroenterology, vol. 43, no. 4, p. 403-409

Publication date2019

Abstract

During the past decade, mTOR inhibitors (mTORi), everolimus and sirolimus, have been increasingly used after adult liver transplantation (LT). The aim of the present study was to describe the use of mTORi in pediatric LT recipients.

Keywords

Liver transplantation
Pediatric
MTOR inhibitor
Outcome

Affiliation entities

Faculté de médecine / Section de médecine clinique / Département de pédiatrie, gynécologie et obstétrique

Research groups

Citation (ISO format)

DUMORTIER, Jérôme et al. mTOR inhibitors in pediatric liver transplant recipients. In: Clinics and Research in Hepatology and Gastroenterology, 2019, vol. 43, n° 4, p. 403–409. doi: 10.1016/j.clinre.2018.11.010

Article (Published version)

Identifiers

PID : unige:136386
DOI : 10.1016/j.clinre.2018.11.010
PMID : 30528864

Additional URL for this publicationhttps://www.sciencedirect.com/science/article/pii/S2210740118302675

Journal ISSN2210-7401

267views

2downloads

Creation11/11/2019 16:22:00

First validation11/11/2019 16:22:00

Update19/09/2025 10:11:50

Status update19/09/2025 10:11:50

Last indexation19/09/2025 10:15:26

Archive ouverte UNIGE

mTOR inhibitors in pediatric liver transplant recipients

During the past decade, mTOR inhibitors (mTORi), everolimus and sirolimus, have been increasingly used after adult liver transplantation (LT). The aim of the present study was to describe the use of mTORi in pediatric LT recipients.

Technical informations